Natesto Effects on Testosterone, Luteinizing Hormone, Follicle Stimulating Hormone and Semen Parameters
Phase of Trial: Phase IV
Latest Information Update: 17 Oct 2019
Price : $35 *
At a glance
- Drugs Testosterone (Primary)
- Indications Hypogonadism
- Focus Therapeutic Use
- 17 Oct 2019 According to an Aytu BioScience media release, 55 men were eligible and enrolled in the trial. Of the 55 who enrolled, 44 patients have completed the three-month treatment period. Thirty-three patients have completed the six-month treatment period.
- 17 Oct 2019 Results published in an Aytu BioScience Media Release
- 17 Oct 2019 According to an Aytu BioScience media release, data were presented at the 75th Annual American Society for Reproductive Medicine (ASRM) Scientific Conference.